Afinion™ HbA1c, Afinion™ 2 and Alere Afinion™ AS100 Analyzer
Assay, Glycosylated Hemoglobin. 510(k) K214117, from Abbott Diagnostics Technologies AS (Oslo, NO). Product code LCP, class 2.
As of Nov 19, 2026, K214117 is an FDA 510(k) held by Abbott Diagnostics Technologies AS, substantially equivalent on Sep 27, 2023 after 636 days, with no recalls tied to it in FDA's recall database.
- Review time: 636 days
- Recalls: 0
Afinion™ HbA1c Afinion™ HbA1c is an in vitro diagnostic test for quantitative determination of glycated hemoglobin (% hemoglobin A1c, HbA1c) in venous and capillary human whole blood. The measurement of % HbA1c is recommended as a marker of long-term metabolic control in persons with diabetes mellitus.
- Alere Afinion HbA1c and ACR on Afinion 2 analyzerK171650 · Abbott Rapid Diagnostics · Nov 21, 2017
- Alere Afinion HbA1c, Alere Afinion AS100 AnalyzerK151809 · Alere Technologies AS · Sep 25, 2015
- Afinion HbalcK050574 · Axis-Shield Poc AS · Jul 22, 2005
- Afinion AnalyzerK110056 · Axis-Shield Poc AS · Feb 15, 2011
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Dual Track
- Received
- Dec 30, 2021
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files